Get started
Author

Alice Moncada

Mutations in the 3′ untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis
2013 · Mario Sabatelli, Alice Moncada, et al. · Human Molecular Genetics · 108
ATXN2 polyQ intermediate repeats are a modifier of ALS survival
2014 · Adriano Chiò, Andrea Calvo, et al. · Neurology · 66
PDF
HIPK2 Controls Cytokinesis and Prevents Tetraploidization by Phosphorylating Histone H2B at the Midbody
2012 · Cinzia Rinaldo, Alice Moncada, et al. · Molecular Cell · 62
PDF
Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations
2015 · Mario Sabatelli, Marcella Zollino, et al. · Neurobiology of Aging · 58
HIPK2 Regulation by MDM2 Determines Tumor Cell Response to the p53-Reactivating Drugs Nutlin-3 and RITA
2009 · Cinzia Rinaldo, Andrea Prodosmo, et al. · Cancer Research · 50
Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome
2015 · Concetta Cafiero, Giuseppe Marangi, et al. · European Journal of Human Genetics · 49
PDF
HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicity
2015 · Davide Valente, Gianluca Bossi, et al. · Oncotarget · 38
PDF
Lab tests for MPN
2021 · Alice Moncada, Alessandro Pancrazzi · International review of cytology · 7
BL-MOL-AR Project, Preliminary Results about Liquid Biopsy: Molecular Approach Experience and Research Activity in Oncological Settings
2023 · Alessandro Pancrazzi, Francesco Bloise, et al. · Global Medical Genetics · 2
PDF
Supplementary Figure 2 from HIPK2 Regulation by MDM2 Determines Tumor Cell Response to the p53-Reactivating Drugs Nutlin-3 and RITA
2023 · Cinzia Rinaldo, Andrea Prodosmo, et al.
Supplementary Figure 1 from HIPK2 Regulation by MDM2 Determines Tumor Cell Response to the p53-Reactivating Drugs Nutlin-3 and RITA
2023 · Cinzia Rinaldo, Andrea Prodosmo, et al.
PDF
Supplementary Figure 3 from HIPK2 Regulation by MDM2 Determines Tumor Cell Response to the p53-Reactivating Drugs Nutlin-3 and RITA
2023 · Cinzia Rinaldo, Andrea Prodosmo, et al.
PDF
Supplementary Figure 3 from HIPK2 Regulation by MDM2 Determines Tumor Cell Response to the p53-Reactivating Drugs Nutlin-3 and RITA
2023 · Cinzia Rinaldo, Andrea Prodosmo, et al.
Data from HIPK2 Regulation by MDM2 Determines Tumor Cell Response to the p53-Reactivating Drugs Nutlin-3 and RITA
2023 · Cinzia Rinaldo, Andrea Prodosmo, et al.
Data from HIPK2 Regulation by MDM2 Determines Tumor Cell Response to the p53-Reactivating Drugs Nutlin-3 and RITA
2023 · Cinzia Rinaldo, Andrea Prodosmo, et al.
Experience of Uncommon EGFR Mutation in Lung Scheme Quality Program: Discussing Risks and Opportunities for the Improvement of Laboratory Response
2021 · Alessandro Pancrazzi, Agostino Ognibene, et al. · Global Medical Genetics
PDF
467 HIPK2 in the Control of Chromosomal Instability – a New Mechanism in Tumorigenesis
2012 · D. Valente, A. Moncada, et al. · European Journal of Cancer
HIPK2 Controls Cytokinesis through Histone H2B Phosphorylation at the Midbody
2012 · Moncada, Alice · UnitusOpen (Tuscia University)
Works count: 18
Citation count: 440
H-index: 7
I10-index: 7
Year
Topic
Type